03/09/24 -"Following the company’s profit warning, we have cut our 2024 EBITDAR forecast from €822m to €728m (-11.4%), mainly to reflect the tougher post-scandal rebuild in French nursing homes (revenue -3.2% ..."
Pages
56
Language
English
Published on
03/09/24
You may also be interested by these reports :
22/01/26
CZM’s Q1 FY 2025-26 preliminary release fell short of market expectations. Sales and profitability were adversely affected by both external and ...
19/01/26
Drägerwerk has delivered solid FY25 preliminary numbers. The key surprise was EBIT, which beat consensus by c.18%, reflecting better gross margins ...
15/01/26
In late-2024, when we last teased the story of DiaSorin (BUY; Italy), a family-owned in-vitro diagnostic company specialising in immunodiagnostics ...
07/01/26
Yesterday, Meta announced a delay in the international rollout of the Ray-Ban display smart glasses. The market reacted positively to this news, on ...